Molecular Genetics Studies of Cancer Patients and Their Relatives (NCT04185935)

🧪 Interventions in This Study

• Biospecimen Collection (OTHER)
• Questionnaire Administration (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (42 Sites)

Showing the first 25 of 42 sites.

• Valleywise Comprehensive Health Center - Phoenix — Phoenix, Arizona
• John Muir Medical Center-Concord Campus — Concord, California
• City of Hope Medical Center — Duarte, California
• Saint Jude Medical Center — Fullerton, California
• Saddleback Memorial Medical Center — Laguna Hills, California
• USC / Norris Comprehensive Cancer Center — Los Angeles, California
• Saint Joseph Hospital - Orange — Orange, California
• Sutter Cancer Centers Radiation Oncology Services-Roseville — Roseville, California
• Cancer Center of Santa Barbara — Santa Barbara, California
• Lynn Regional Cancer Center - West — Boca Raton, Florida
• Holy Cross Hospital — Fort Lauderdale, Florida
• Kootenai Cancer Center — Post Falls, Idaho
• John H Stroger Jr Hospital of Cook County — Chicago, Illinois
• Rush University Medical Center — Chicago, Illinois
• Mercy Hospital — Cedar Rapids, Iowa
• Suburban Hospital — Bethesda, Maryland
• Frederick Oncology Hematology Associates — Frederick, Maryland
• Steward Saint Elizabeth's Medical Center — Brighton, Massachusetts
• Hunterdon Medical Center — Flemington, New Jersey
• Lovelace Medical Center-Downtown — Albuquerque, New Mexico
• New Mexico Oncology Hematology Consultants — Albuquerque, New Mexico
• Presbyterian Kaseman Hospital — Albuquerque, New Mexico
• Mount Kisco Medical Group at Northern Westchester Hospital — Mount Kisco, New York
• Health Quest Medical Practice PC-Cardio Thoracic — Poughkeepsie, New York
• Aultman Health Foundation — Canton, Ohio

📞 Contact the Study Coordinator

Phone: (602) 344-5368

Email: Ian_Komenaka@dmgaz.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Malignant Neoplasm

• Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment — Duarte, California
• Reproductive Health Program in Patients With Cancer — Jonesboro, Arkansas
• rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy — Houston, Texas
• Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer — Newark, Delaware
• Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families — Houston, Texas
• Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies — Los Angeles, California

Explore by condition: All Malignant Neoplasm clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.